BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 17304034)

  • 21. To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran.
    Rashidi H; Ramezani Tehrani F; Bahri Khomami M; Tohidi M; Azizi F
    Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():100-5. PubMed ID: 24411130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polycystic ovary syndrome.
    King J
    J Midwifery Womens Health; 2006; 51(6):415-22. PubMed ID: 17081931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age.
    Pasquali R; Gambineri A
    Ann N Y Acad Sci; 2006 Dec; 1092():158-74. PubMed ID: 17308142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgens in polycystic ovary syndrome: the role of exercise and diet.
    Giallauria F; Palomba S; Vigorito C; Tafuri MG; Colao A; Lombardi G; Orio F
    Semin Reprod Med; 2009 Jul; 27(4):306-15. PubMed ID: 19530064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of polycystic ovary syndrome among the privately insured, United States, 2003-2008.
    Okoroh EM; Hooper WC; Atrash HK; Yusuf HR; Boulet SL
    Am J Obstet Gynecol; 2012 Oct; 207(4):299.e1-7. PubMed ID: 22921097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The controversies in the diagnosis of polycystic ovary syndrome].
    Katulski K; Czyzyk A; Meczekalski B
    Pol Merkur Lekarski; 2012 Jul; 33(193):32-7. PubMed ID: 22993908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of the polycystic ovary syndrome in female residents of Chengdu, China.
    Zhuang J; Liu Y; Xu L; Liu X; Zhou L; Tang L; Kang D; Guo W; He M; Yang F; Qiu D
    Gynecol Obstet Invest; 2014; 77(4):217-23. PubMed ID: 24751759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of leptin in polycystic ovary syndrome].
    Marciniak A; Starczewski A
    Pol Merkur Lekarski; 2008 Oct; 25(148):390-3. PubMed ID: 19145943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polycystic ovary syndrome: a common but often unrecognized condition.
    Shannon M; Wang Y
    J Midwifery Womens Health; 2012; 57(3):221-30. PubMed ID: 22594862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Physiopathological link between polycystic ovary syndrome and hyperprolactinemia: myth or reality?].
    Robin G; Catteau-Jonard S; Young J; Dewailly D
    Gynecol Obstet Fertil; 2011 Mar; 39(3):141-5. PubMed ID: 21388855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth.
    Diamanti-Kandarakis E; Piperi C
    Hum Reprod Update; 2005; 11(6):631-43. PubMed ID: 15994846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM; Wass JA; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polycystic ovary syndrome and its differential diagnosis.
    Lane DE
    Obstet Gynecol Surv; 2006 Feb; 61(2):125-35. PubMed ID: 16433936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?
    Abbott DH; Barnett DK; Bruns CM; Dumesic DA
    Hum Reprod Update; 2005; 11(4):357-74. PubMed ID: 15941725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria.
    Shroff R; Syrop CH; Davis W; Van Voorhis BJ; Dokras A
    Fertil Steril; 2007 Nov; 88(5):1389-95. PubMed ID: 17462641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
    Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M
    Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome.
    Ben Ayed B; Dammak dit Mlik S; Ben Arab H; Trabelssi H; Chahtour H; Mathlouthi N; Dhuib M; Kassis M; Saiidane D; Trabelssi K; Guermazi M
    Tunis Med; 2009 Jan; 87(1):43-9. PubMed ID: 19522426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polycystic ovarian syndrome: role of imaging in diagnosis.
    Lee TT; Rausch ME
    Radiographics; 2012 Oct; 32(6):1643-57. PubMed ID: 23065162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic criteria for polycystic ovary syndrome: a reappraisal.
    Azziz R
    Fertil Steril; 2005 May; 83(5):1343-6. PubMed ID: 15866567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women.
    Shi Y; Gao X; Sun X; Zhang P; Chen Z
    Fertil Steril; 2008 Oct; 90(4):1139-43. PubMed ID: 17889857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.